Over-the-counter pain medicine comparison for period cramps in women with Crohn's disease
Official title: Acetaminophen Versus Ibuprofen for Discomfort in Crohn's Disease (AVID-CD): An Open-Label Randomized Pilot Trial
Run by University of North Carolina, Chapel Hill · NCT07337902 · Data updated 2026-11-12
This pilot will test whether ibuprofen or acetaminophen relieves period cramps more effectively and safely for women aged 18–44 who have Crohn's disease in remission.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 44 Years |
| Sex | Women only |
| Enrollment | 24 (estimated) |
| Sponsor | University of North Carolina, Chapel Hill Academic / other |
| Locations | 1 site (Chapel Hill, North Carolina) |
| Status | Recruiting |
| Started | March 18, 2026 |
| Main results expected | July 2028 |
| Study ends | July 2028 |
| Registry record updated | July 14, 2026 |
| Trial ID | NCT07337902 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people assigned female at birth, aged 18–44, with a confirmed Crohn's disease diagnosis who are in stable remission (CDAI <150), have regular menstrual cycles and primary dysmenorrhea, and are using reliable contraception or abstinence.
✕Probably not a fit
Those unlikely to benefit include people with active Crohn's disease, current pregnancy, other pelvic pathologies (for example endometriosis or fibroids), recent or unstable hormonal contraceptive use, or anyone outside the specified age or sex-at-birth criteria.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot enrolls people assigned female at birth, ages 18–44, with Crohn's disease in stable clinical remission and self-reported primary dysmenorrhea. Participants complete a screening visit with a blood draw, pregnancy test, stool testing, a physical exam, and questionnaires, then continue the rest of the study at home. They will be assigned to take either ibuprofen or acetaminophen for four menstrual cycles and asked to submit samples and complete surveys. Investigators will track feasibility outcomes including recruitment, adherence to the medication plan, retention through the study, and completion of study activities to inform a larger trial.
Why it matters
Potential benefit: If successful, the project could clarify which common over-the-counter pain medicine provides better period-cramp relief without worsening Crohn's disease, giving clearer guidance for symptom management.
How similar studies have gone: There is limited prior research directly comparing ibuprofen and acetaminophen for menstrual pain specifically in people with Crohn's disease, and concerns about NSAID effects on IBD make this a relatively novel and cautious pilot approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Ages 18-44 years * Assigned female at birth * Crohn's Disease (CD) diagnosis * In stable clinical remission from CD, defined as a short Crohn's Disease Activity Index (CDAI; See Table 3) \<150 without use of corticosteroids * Self-reported primary dysmenorrhea * Regular menstrual cycles occurring every 23-35 days * Using an appropriate contraceptive method or abstinence Exclusion Criteria: * Any of the following conditions: endometriosis, adenomyosis, polycystic ovarian syndrome, endometrial fibroids/polyps, chronic pelvic inflammatory disease, a history of pelvic surgery including hysterectomy, any other pathological pelvic conditions, or current pregnancy * Plans to become pregnant during the study period * Use of an oral contraceptive for less than 3 months, on an unstable oral contraceptive dose within the last 3 months, switched from one oral contraceptive to another within the last 3 months or intend to do so during the course of the trial * Taking hormone therapy including estrogen or progesterone that is not part of a hormonal contraceptive * Known hypersensitivity or contraindication to ibuprofen or acetaminophen * Inability to complete REDCap questionnaires (including confusion despite training and/or lack of smart phone and/or computer access). * Not able to speak and read English language.
Where it's running
-
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Erica J Brenner, MD, MSCR — University of North Carolina, Chapel Hill
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nonpharmacologic therapies for menstrual pain in young women with primary dysmenorrhea
This study tests whether vibration therapy, abdominal massage, or myofascial release can help reduce menstrual pain in women aged 18–30 who have primary dysmenorrhea, compared with education alone.
-
Ultrasound-guided margin choice during ileocolic resection for Crohn's disease
This trial tests whether using ultrasound to guide how much tissue to remove during ileocolic surgery for terminal ileal Crohn's disease helps people see better outcomes than using the usual surgeon-determined margins.
-
Tailored Anti-Inflammatory Diet for Crohn's Disease
This study tests a personalized anti-inflammatory diet for people with Crohn’s disease to see if it improves symptoms and inflammation and to find biomarkers of response.
-
Ketogenic versus Carnivore (Lion) diets for inflammatory bowel disease and rheumatoid arthritis
This trial will test whether a ketogenic diet or a carnivore (lion) diet can reduce symptoms, improve quality of life, and lower inflammation in adults with IBD or rheumatoid arthritis.
-
Biologics plus a 6-week enteral nutrition plan for children with Crohn's disease
This will test whether giving children and teens (6–18) with active Crohn's disease a 6-week specialised liquid diet alongside biologic drugs helps them achieve and stay in remission.
-
High-intensity interval training to reduce menstrual pain and improve menstrual health in women with primary dysmenorrhea
This 12-week program will try supervised online high-intensity interval training plus a menstrual health workshop to see if it reduces menstrual pain and improves quality of life for women aged 18–40 with primary dysmenorrhea.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.